The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,425.00
Bid: 2,390.00
Ask: 2,405.00
Change: 0.00 (0.00%)
Spread: 15.00 (0.628%)
Open: 2,435.00
High: 2,435.00
Low: 2,390.00
Prev. Close: 2,425.00
MGNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Voting Update

4 Sep 2023 12:51

RNS Number : 3096L
Morgan Sindall Group PLC
04 September 2023
 

Morgan Sindall Group plc

Legal Entity Identifier (LEI) number: 2138008339ULDGZRB345

 

4 September 2023

Morgan Sindall Group plc ("the Company")

 

Update on response to 2023 AGM voting outcome

 

At our Annual General Meeting ('AGM') held on 4 May 2023, resolution 3 (Approval of the Directors' Remuneration Policy) was supported by a large majority of shareholders but received less than 80% support overall.

 

In advance of the 2023 AGM, the Remuneration Committee (the 'Committee') undertook a detailed engagement with the Company's largest shareholders in relation to the remuneration proposals, and had amended the final Remuneration Policy design in response to feedback received. Following the 2023 AGM, the Committee reached out to the Company's largest shareholders to continue the dialogue and listen to their views - and in particular to understand why those who either abstained or voted against the Directors' Remuneration Policy ('the 'Policy') had done so.

 

The Committee received responses from eight investors, the majority of whom reconfirmed support for the Policy and the management team. 

 

One shareholder raised the annual bonus deferral requirement and 2nd-year phasing down of the post-employment shareholding requirement as their reason for not supporting the resolution. In both cases the Committee is comfortable that its current approach supports appropriate alignment of executive and shareholder interests. In respect of the annual bonus deferral requirement, the Committee also considers this requirement appropriate given the current shareholdings of incumbent Executive Directors. However, the Committee will reconsider both of these Policy design features as part of the next Policy review.

 

The Committee also received feedback from two shareholders that their voting had reflected the 'against' recommendation from one of the major proxy voting agencies, which itself was primarily a result of the simultaneous increases to the Policy headroom available under the annual bonus and LTIP schemes. On this matter, the Committee maintains its view that the Policy should be sufficiently flexible to last for a full triennial review period rather than needing to revert to shareholders to seek incremental changes, and reiterates its commitment to write out to major shareholders in advance of using the increased maximum opportunities under either of the variable incentives.

 

Another shareholder requested that the Committee provide a full explanation in its Remuneration Report of the rationale for the adoption of any increase to the executive directors' incentive opportunities in future years, particularly in relation to the achievement of key strategic objectives, and this feedback is consistent with the current thinking of the Committee.

 

The Committee continues to be grateful for the feedback received and the two-way engagement with major shareholders. Given overall majority support was obtained for the Policy resolution, it is not proposed to make any further changes to the approach to remuneration that was set out in the 2022 Annual Report. The Company will, however, continue to keep the Policy under review over the coming years and welcomes ongoing dialogue with shareholders and proxy advisers.

 

 

Enquiries:

Clare Sheridan, Company Secretary +44 (0) 20 7307 9200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFZLFBXKLEBBF
Date   Source Headline
16th Mar 20223:03 pmRNSDirector/PDMR Shareholding
16th Mar 20229:23 amRNSDirector/PDMR Shareholding
16th Mar 20229:21 amRNSDirector/PDMR Shareholding
8th Mar 20224:00 pmRNSAdditional Listing
8th Mar 20228:27 amRNSHolding(s) in Company
7th Mar 20221:55 pmRNSDirector/PDMR Shareholding
7th Mar 20221:51 pmRNSDirector/PDMR Shareholding
4th Mar 20224:04 pmRNSDirector/PDMR Shareholding
4th Mar 20224:00 pmRNSDirector/PDMR Shareholding
1st Mar 20222:39 pmRNSTotal Voting Rights
24th Feb 20227:00 amRNSFinal Results
7th Feb 20227:00 amRNSNotice of Results
1st Feb 202211:41 amRNSTotal Voting Rights
4th Jan 20223:15 pmRNSTotal Voting Rights
21st Dec 202111:42 amRNSDirector Declaration
7th Dec 20212:26 pmRNSAdditional Listing
30th Nov 20214:53 pmRNSTotal Voting Rights
9th Nov 202112:51 pmRNSAdditional Listing
3rd Nov 20217:00 amRNSTrading Update
1st Nov 20219:24 amRNSTotal Voting Rights
20th Oct 202110:57 amRNSBlock listing Interim Review
20th Oct 20218:43 amRNSChange in Directors' Details
7th Oct 20218:44 amRNSAdditional Listing
4th Oct 20213:27 pmRNSHolding(s) in Company
1st Oct 20219:50 amRNSTotal Voting Rights
24th Sep 20218:00 amRNSHolding(s) in Company
22nd Sep 20218:19 amRNSHolding(s) in Company
7th Sep 20211:19 pmRNSAdditional Listing
2nd Sep 20217:26 amRNSHolding(s) in Company
1st Sep 202111:44 amRNSTotal Voting Rights
10th Aug 20213:13 pmRNSAdditional Listing
9th Aug 20214:26 pmRNSDirector/PDMR Shareholding
4th Aug 20217:00 amRNSHalf-year Report
2nd Aug 20219:37 amRNSTotal Voting Rights
22nd Jul 20217:00 amRNSTrading Update and Outlook for 2021
13th Jul 20217:00 amRNSNotice of Results
1st Jul 20211:22 pmRNSTotal Voting Rights
21st Jun 20215:34 pmRNSHolding(s) in Company
15th Jun 20212:30 pmRNSAdditional Listing
1st Jun 202111:12 amRNSTotal Voting Rights
18th May 20212:00 pmRNSAdditional Listing
6th May 202112:32 pmRNSResult of AGM
6th May 20217:00 amRNSAGM Statement
4th May 20219:05 amRNSTotal Voting Rights
23rd Apr 20213:04 pmRNSHolding(s) in Company
23rd Apr 20218:49 amRNSHolding(s) in Company
22nd Apr 20213:33 pmRNSDirector/PDMR Shareholding
22nd Apr 20217:00 amRNSTrading Update
21st Apr 20219:21 amRNSBlock listing Interim Review
9th Apr 20214:03 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.